Stand Up 2 HPV: Improving HPV Vaccination Rates

This study, called "Stand Up 2 HPV," is looking for ways to increase vaccination rates for the Human Papillomavirus (HPV) in children aged 9 to 17. HPV can cause serious cancers, but many young people are not vaccinated. This study will test two approaches: training healthcare staff (providers and nurses) on how to talk about HPV vaccination, and training them to use "standing orders." Standing orders are written instructions that allow nurses to give vaccines without needing a doctor's specific approval for each patient. The goal is to see if these methods lead to more opportunities for patients to receive the HPV vaccine over a 12-month period. You can join if you are an active patient in an AHP practice and are between 9 and 17 years old. The study is not recruiting from practices that already have very high HPV vaccination rates or very few eligible 11-12 year olds.

Study design
This is an interventional study aiming to enroll 16,000 participants. It is not specified if it is randomized or blinded.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, patient-level captured opportunities for HPV vaccination, is measured at a 12-month intervention period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06380114

Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination

Recruiting
NAAges 9–17InterventionalHealth services
University of Rochester
~16,000 participants
Updated 2026-05-29 on ClinicalTrials.gov
What's tested:CommunicationStanding Orders

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient-Level Captured Opportunities for HPV Vaccination
Measured over 12-month intervention period
Hpv
1 sites across 1 states
New York1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

active patient in AHP practice

Exclusion

patient belonging to a practice with \>80% UTD baseline HPV vaccination rate for ages 13-17
patient belonging to a practice with \<20 11-12 year-olds eligible for an HPV dose
  • Patient-Level Captured Opportunities for HPV Vaccination12-month intervention period

    The percentage of HPV vaccine eligible patients, aged 9-17, with a practice visit during the specified timeframe of interest who receive \>=1 HPV vaccination.